All Things Cardio-Oncology International Cardio-Oncology Society

Karlis Trusinskis, MD President of IC-OS Latvia chapter speaks about the challenges and opportunities of cardio-oncology care in his country.

Diego Sadler, MD

Section Head Cardio Oncology, Cleveland Clinic Florida

In this episode Dr. Sadler speaks about his pioneering work with the Global Cardio-Oncology Registry. This is the first in kind registry that aims to enroll cardio-oncology patients from around the world. GCOR is a multinational, multicenter prospective observational cohort registry and will collect clinical, laboratory, imaging, demographic and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular disease.

Dr. Anju Nohria is the Director of the Cardio-Oncology Program at Dana-Farber Brigham Cancer Center and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is an Assistant Professor of Medicine at Harvard Medical School (HMS).

On this episode she discusses the challenges and opportunities of starting a new clinic focused on cardio-oncology care.

Renato Lopes, MD, PhD, FACC

Renato Delascio Lopes

Professor of Medicine

Duke University, School of Medicine

Professor of Medicine Divisions of Internal Medicine and Cardiology, Federal University of Sao Paulo, Sao Paulo, Brazil

Dr. Lopes discusses his ongoing efforts to develop, produce, and distribute cardio-oncology education in Brazil and the United States.  

Dr Vivek Narayan is an Assistant Professor of Medicine at Hospital of the University of Pennsylvania, Philadelphia, US.



View the entire webinar here:
https://www.radcliffecardiology.com/video-index/renal-cell-carcinoma-and-vegf-tki-cardiovascular-toxicity

Richard Cheng MD, MSc. is cardiology faculty at the University of Washington, Seattle, with a focus in cardiomyopathies, cardio-oncology and cardiac imaging. He is Program Director for the HF fellowship and the Director of the Cardio-oncology Program. He has formal training with a Masters-in-Science in clinical trial design and biostatistics. He has extensive editorial experience, including serving on the editorial boards for JACC, JACC: Cardio-oncology, JHLT, and is an associate editor for Heart (BMJ). Additionally, he is topic (section) editor for cardiomyopathies for ACC/HFSA HFSAP and an associate editor for ACC.org for heart failure and cardiomyopathies. His research focus over the last several years has been on risk stratification in heart failure, cardiac amyloidosis, and cardio-oncology cohorts.



Read the full manuscript here:

https://heart.bmj.com/content/early/2024/01/24/heartjnl-2023-323502



Donate to the Rachel Levine Amyloidosis Awareness Fund here:

https://ic-os.info/RachelDaraLavineFund